Johnson & Johnson is an American multinational medical devices,
pharmaceutical and consumer packaged goods manufacturer founded in 1886.
Its common stock is a component of the Dow Jones Industri...
Mar 29, 2013 ... J&J Wins U.S. Approval for First-in-Class Diabetes Drug. Anna Edney ... “I worry
its use in women will be somewhat minimal,” Butler said.
Mar 29, 2013 ... FDA has approved a new diabetes drug from Johnson & Johnson, making it the
first in its class to be approved in the United States. ... of biologic drugs must wait
six months after winning federal approval to begin selling them.
Apr 21, 2014 ... Johnson's Invokana is about to face a host of new SGLT2 competitors ... Since
Invokana helped lift Johnson's first-quarter sales in the U.S. last quarter, let's look
at its ... Express Scripts expects spending on diabetes treatment will grow 11% in
... the first in a new class of diabetes drugs to win FDA ap...
Apr 1, 2013 ... And J&J ($JNJ) will have to spend a pretty penny on detailing and advertising to
... And it's true that diabetes patients often have to change meds to keep control of
... J&J wins first FDA approval for new class of diabetes drug
Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly
half of ... Janssen will partner with other Johnson & Johnson companies focused
on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.
Mar 29, 2013 ... The approval gives the healthcare giant its first market green light for a new ...
UPDATED: J&J wins first FDA approval for new class of diabetes drug ... with a
relatively high rate of genital infections which will limit uptake in our ...
On its approval, analysts expected peak sales of around $650 million for
Invokana, but competitors ... a diabetes drug, and the heads of its Janssen unit
hope Invokana's success will ... J&J wins first FDA approval for new class of
Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ...
As the first company to win FDA approval, Johnson & Johnson has a leg up on
industry rivals developing their own ... More details on the studies will be
presented at the American Diabetes Association annual meeting in June.
Oct 14, 2016 ... Most type 2 diabetes drugs manipulate insulin levels, which could lead to
complications ... Johnson & Johnson, the manufacturer of Invokana, received
approval for the drug from the FDA in 2013. ... How does Invokana work? ... It's
important to keep track of your blood sugar levels and know the symptoms of ....